(Reuters) – Drugmaker Pfizer Inc on Wednesday filed a lawsuit against Johnson & Johnson , saying its rival’s contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and blocked sales of Pfizer’s new biosimilar.

Continue reading on Reuters

Leave a Reply

Your email address will not be published. Required fields are marked *